← FDA Drug Approvals (Drugs@FDA)

CYTARABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2004-01-15

Drug application

FDA Application #
ANDA076512
Application type
Abbreviated New Drug Application (Generic)
Brand name
CYTARABINE
Generic name
CYTARABINE
Active ingredients
CYTARABINE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
FRESENIUS KABI USA
Manufacturer
Fresenius Kabi USA, LLC
First approval
2004-01-15

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown